Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Bellicum Pharmaceuticals
(BLCM) Q4 2022
Earnings
BLCM
Mar 31
Confirmed
May 2022
Aug 2022
Nov 2022
Q4 2022
-0.93
-0.66
-0.4
-0.13
Details
Expected EPS
-0.93
Actual EPS
-0.2
Surprise EPS
0.73
Surprise Percent
+78.49%
Description
Bellicum Pharmaceuticals (BLCM) has reported earnings of -0.2 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login